ITGAV and cancer: The analysis revealed significant correlations between ITGAV expression and PFS in several cancers, including adrenocortical carcinoma (ACC), GBM, KIRC, KIRP, LGG, LIHC, PAAD, STAD, and UCEC (Fig. 5A).